Skip to content
Disclosery

EXANE DERIVATIVES: BTG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BTG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 154,138 BTG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 154,138 shares
    Change vs previous 13F -1,067 shares

    0.3% of the 13F portfolio, value $522,421.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 155,205 shares
    Change vs previous 13F not available

    0.2% of the 13F portfolio, value $712,347.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).